Patent application number | Description | Published |
20100023079 | Cardiac Pacing Methods and Apparatus - A method and apparatus is provided for determining whether a current atrial-ventricular (AV) delay during cardiac pacing is appropriate for proper mechanical coupling of the atrium and ventricle. If proper mechanical coupling is determined to not exist, an additional atrial contraction is induced within the same ventricular cycle to maintain atrial-ventricular mechanical coupling. | 01-28-2010 |
20110106200 | STROKE RISK MONITORING SYSTEM INCLUDING IMPLANTABLE MEDICAL DEVICE - One or more example techniques for monitoring the stroke risk of a patient via a system including an implantable medical device. In some examples, a method including monitoring at least one physiological parameter of a patient via an implantable medical device; determining whether each of a plurality stroke risk factors are present based at least in part on the at least one physiological parameters monitored via the implantable medical device; and generating a stroke risk score based on the stroke risk factors determined to be present, wherein the stroke risk score is reflective of the patient's risk of stroke. | 05-05-2011 |
20110319723 | System for Characterizing Chronic Physiological Data - An implantable medical device (IMD) senses physiological episodes and stores data associated with the physiological episodes in the IMD. The data is then processed based on a pattern of recurrence of the physiological episodes. | 12-29-2011 |
20120109675 | SYSTEM AND METHOD FOR IDENTIFYING A PROSPECTIVE CLINICAL THERAPY FOR A PROSPECTIVE PATIENT HAVING A MEDICAL DEVICE - System and method for identifying a prospective clinical therapy for a prospective patient. The patient has a medical device, performed with a medical apparatus. The system has a historical database and an analyzer. The historical database incorporates information relating to a multiplicity of patients, each of the multiplicity of patients having a medical device and each of the multiplicity of patients having undergone a clinical therapy, the information including, for each of the multiplicity of patients, device characteristics of the medical device and an assessment of efficacy of clinical therapy. The analyzer correlates device characteristics of the prospective patient with the device characteristics and the assessment of efficacy of clinical therapy of the multiplicity of patients using the historical database to identify a prospective clinical therapy for the prospective patient associated with the device characteristics in the historical database having a relatively greater efficacy than the clinical therapy. | 05-03-2012 |
20120185007 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 07-19-2012 |
20120185008 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 07-19-2012 |
20120185009 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 07-19-2012 |
20120185010 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 07-19-2012 |
20120290030 | AV NODAL STIMULATION DURING ATRIAL TACHYARRHYTHMIA TO PREVENT INAPPROPRIATE THERAPY DELIVERY - The disclosure describes techniques for delivering electrical stimulation to decrease the ventricular rate response during an atrial tachyarrhythmia, such as atrial fibrillation. AV nodal stimulation is employed during an atrial tachyarrhythmia episode with rapid ventricular conduction to distinguish ventricular tachyarrhythmia from supraventricular tachycardia and thereby prevent delivering inappropriate therapy to a patient. | 11-15-2012 |
20130079646 | PHYSIOLOGICAL PERTURBATIONS FOR MEASURING HEART FAILURE - Techniques of inducing a physiological perturbation to monitor a heart failure status of a patient are described. An implantable medical device (IMD) may induce a physiological perturbation in the patient to monitor and determine how the patient responds to the physiological change. This response may be indicative of heart failure improvement or worsening. For example, the IMD may deliver electrical stimulation with parameters configured to perturb the patient (e.g., stimulation that deviates from stimulation therapy). The IMD may then detect at least one physiological parameter to monitor the patient's response to the perturbation. Based on the detected physiological parameter, the IMD may generate a heart failure status. The heart failure status may then be used for adjusting patient therapy, with or without the use of remote monitoring. | 03-28-2013 |
20140316486 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 10-23-2014 |
20140324115 | VAGAL STIMULATION - The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions. | 10-30-2014 |